Introduction
In mammals, inflammatory processes lead inter alia to the recruitment of neutrophils. Among other possibilities to counteract an invasion of pathogens, neutrophils can form a meshwork comprised of DNA and histones, together with antimicrobial molecules [1, 2] . These neutrophil extracellular traps (NET) are formed to immobilize and kill pathogens [3] . However, extracellular histones released in this way can also damage host cells during diseases with amplified NET assembly such as sepsis, systemic lupus erythematosus, and cystic fibrosis [4] [5] [6] [7] [8] .
Interestingly, a2,8-linked polymers of N-acetylneuraminic acid (Neu5Ac) residues have been shown to neutralize the histone-mediated cytotoxicity [7, 9] . Such polysialic acid (polySia) chains can be present as a post-translational modification of distinct proteins in vertebrates as well as invertebrates [10] [11] [12] [13] [14] [15] [16] . The capsule of several bacterial strains can also contain such Abbreviations DMB, 4,5-methylene dioxybenzene; endoN, endoneuraminidase; mAb, monoclonal antibody; NET, neutrophil extracellular traps; Neu5Ac, N-acetylneuraminic acid; polySia, polysialic acid; polySiaT, polysialyltransferase.
sialic acid polymers [12, 15, [17] [18] [19] . In mammals, a natural occurring cytoprotective interaction between polySia chains and NET was already suggested during inflammatory processes in the lung as well as after insemination in the female reproductive tract [9, 11] . Because of these protective properties of polySia, the direct administration of this carbohydrate during processes with strong exaggerated NET formation is being discussed as a potential therapeutic strategy [9, 11, 20] .
In addition to their role in diseases like cystic fibrosis, NETs have also been shown to accumulate on sterile implant materials [21] . Such fibrosis-triggering cell products can initiate an impaired efficiency of the implant or even device failure [22] . One possibility for reducing the adhesion of neutrophils and subsequent NET production on implants is to coat the implant surfaces with mucins [23, 24] . Mucins are very strongly O-glycosylated proteins and are extensively expressed by epithelial cells in several organs like the cervix, the intestinal tract, and the lung. Thus, mucins and polySia are carbohydrate-based components that have potential to modulate both NET-mediated cytotoxicity and accumulation of neutrophils on implants.
We wanted to combine these two natural products for prospective medical application against NET. For this purpose, we investigated mucins of different sources, which could act as substrates for bacterial polysialyltransferases (polySiaT) to generate artificial polysialylated mucins in vitro. However, bacterial polySiaT require at least two a2,8-linked sialic acid residues as an acceptor for elongation [25] [26] [27] and most glycoconjugates are only terminated by sialic acid monomers [28] . Nevertheless, we tested bovine cervical mucins, porcine stomach mucins, and chicken intestinal mucins to act as potential acceptors for polySiaT.
In the present study, we showed, in contrast to other sources, that cervical mucus contains oligosialylated mucins, which could be efficiently polysialylated by bacterial polySiaT in vitro. The artificial polySia chains of these modified mucins can comprise more than 50 sialic acid residues and have an enhanced capacity to counteract histone-mediated cytotoxicity.
Results and discussion
PolySia chains consisting of more than 20 sialic acid residues efficiently counteract histonemediated cytotoxicity As already described in many studies, extracellular histones are toxic for eukaryotic cells and this damaging effect is thought to play an important role during numerous pathological processes [4] [5] [6] [7] [8] . Interestingly, the histone-mediated cytotoxicity can be efficiently counteracted by sialic acid polymers [7] . As shown in Fig. 1 , polySia acts in a concentration-dependent manner inactivating the cytotoxicity of histones. In a previous study [7] , and in experiments shown in Fig. 1 , only mixtures of different polySia chain lengths were applied.
However, the treatment of polySia with endoneuraminidase (endoN), which degraded polySia to oligomers (monomers up to heptamers) [29] , leads to a loss of its capacity to inactivate extracellular histones [9] . Consequently, histone binding may depend on the degree of polymerization (DP). To examine the minimal required chain length, commercial available polySia (equivalent to colominic acid) was separated by anion exchange chromatography, and groups of distinct chain lengths (DP 8-20; 21-30; 31-40; 41-50; 51-60; 61-70; 71-80; > 80) were collected according to the retention time of a HPLC chromatogram using fluorescently labeled polySia standards. The chain lengths of all fractions were determined using HPLC after 4,5-methylene dioxybenzene (DMB)-labeling (Fig. 2) .
Subsequently, all fractions were tested for their capacity to counteract the cytotoxicity of extracellular histones. As illustrated in Fig. 3 , only polymers consisting of more than 31 sialic acid residues significantly abolished the histone-mediated cell damage. However, also fraction 'DP 21-30' seems to influence the cytotoxicity. As in all experiments the same amounts of Neu5Ac residues were applied, the results demonstrate that the negative charge by itself plays a minor role. Moreover, the structural organization of these polymers seems to be essential. A chain length-dependent interaction between sialic acid polymers and proteins were already observed for other binding partners [19, 30] . For instance, the neurotrophin brain-derived neurotrophic factor BDNF binds only polySia chains with more than 12 sialic acids residues [31] and the interaction with fibroblast growth factor 2 needs a DP higher than 17 [32] .
In summary, our results demonstrate that in order to display an enhanced capacity of mucins to block the cytotoxicity of extracellular histones in medical applications, it is likely to be necessary to elongate mucins in vitro with chains showing a DP of~30.
Cervical mucins are potential acceptors for bacterial polysialyltransferases
After the examination of the minimal required chain length to counteract the histone-mediated cytotoxicity, a naturally occurring mucin acceptor that would act as a target for bacterial polysialyltransferase was required. Therefore, we compared bovine cervical mucins, porcine stomach mucins, and chicken intestinal mucins. These were incubated with Neisseria meningitis B (NmB) polySiaT. The activity of the polySiaT in the presence of the substrate was measured by supplementation with 14 C-labeled CMP-Neu5Ac. As shown in Fig. 4 , 14 C-labeled Neu5Ac was efficiently incorporated into bovine cervical mucins, but not into porcine stomach mucins or chicken intestinal mucins.
The polySiaT used requires a2,8-linked sialic acid residues as acceptors. Thus, the results indicated that the glycans of this mucin contain not only terminal sialic acid monomers but also oligosialyl and/or polysialyl units.
Characterization of the oligosialylation status of bovine cervical mucins
To test the presence of polySia chains on cervical mucins, a dot blot analysis was performed using the monoclonal antibody (mAb) 735. This mAb requires more than seven linked sialic acid residues [13, 33] . As shown in Fig. 5A , mAb 735 did not efficiently bind cervical mucins. Consequently, the immunostaining suggests that only oligoSia chains are present on cervical mucins.
In order to verify the presence of internal sialic acid residues on bovine cervical mucins, HPLC-based techniques were used. In a first set of experiments, a 'C7/ C9 analysis' was applied [34] [35] [36] . After transformation of all terminal sialic acids into C7 residues by oxidation and subsequent reduction of the resulting aldehyde group, sialic acid residues were cleaved under acidic conditions and labeled with the fluorophore DMB. Only terminal sialic acid residues are oxidized, as no vicinal hydroxyl groups exist on internal sialic acid residues due to the a2,8-linkage. After sample preparation, resulting C7-Neu5Ac-DMB and C9-Neu5Ac-DMB were separated by reversed phase (RP)-HPLC (Fig. 5B) . The detection of C9-Neu5Ac-DMB after periodate oxidation specified the existence of internal sialic acid residues on mucins of bovine cervical mucins, which were resistant to oxidation. The detection of internal sialic acid residues gives, however, no detailed information about the chain length distribution, as the 'C7/C9 analysis' can only be used to distinguish between internal and terminal sialic acid residues.
Therefore, the chain length was analyzed in more detail. OligoSia chains were released under mild acidic conditions and directly tagged with DMB at the ) and the cytotoxicity was determined (blue column). In parallel, cells were cultivated in the presence of histones in addition to increasing concentrations of polySia to analyze the impact of polySia on the cytotoxicity (green columns). Zero percent cytotoxicity was set for untreated cells. All values AE SD are means of three independent experiments. ns, not significant; **, P < 0.01. resulting reducing end. During this one-pot reaction, however, also internal cleavages of polySia chains occur [35] . The fluorescently labeled sialic acid polymers were analyzed by anion exchange chromatography according to the number of linked sialic acid residues. Consistent with the elongation studies and the immunostaining, the chromatographic profiles obtained, showed that oligoSia chains were present on cervical mucins (Fig. 5C ). The released chains can comprise up to three sialic acid residues. In summary, the HPLC-based characterization of cervical mucins revealed the presence of oligoSia chains and verified the results of the polySiaT activity assay demonstrating that bovine cervical mucins can be used as an acceptor for bacterial polySiaT. Interestingly, expression data from bovine cervix and uterus already demonstrated that mRNA of different a2,8-sialyltransferases are present in the female reproductive tract [37, 38] . However, until now it is not known, which mammalian a2,8-sialyltransferase can use glycans on mucins as an acceptor.
PolySia chains of in vitro elongated mucins can consist of more than 50 sialic acid residues Based on the outlined experiments, bovine oligoSia chains of cervical mucins were elongated by NmB polysiaT and resulting products were analyzed by dot blot Fig. 2 . Fractionation of polySia. Defined chain length of (A) DMB-labeled as well as (B) unlabeled sialic acid polymers were purified. The distinct chain lengths of all fractions were controlled by rechromatography as indicated. To this end, unlabeled fractions were fluorescently labeled with DMB before rechromatography. In contrast, previously DMB-labeled polymers could be directly injected. Neu5Ac content of all collected fractions was determined by DMB-HPLC analysis.
analysis using mAb 735. As shown in Fig. 6A , in contrast to native mucins, elongated mucins can be visualized with an anti-polySia mAb. Thus, NmB polySiaT-treated mucins bear polySia chains. For a more detailed analysis, cervical mucins from two different time points of the estrus cycle were elongated to generate a potential therapeutic agent for the inactivation of cytotoxic extracellular histones. NmB polySiaT extended the pre-existing oligoSia chains of mucins collected at both time points of bovine estrus cycle. This was shown on western blots after separation by agarose gel electrophoresis using horse 46 antisera to visualize polySia (Fig. 6B) . The immunostaining could be abolished after degradation of polySia chains by endoN.
As only polySia with more than 30 sialic acid residues are efficient against extracellular histones, the DP of the extended chains was examined after DMB-labeling. The chromatograms obtained from this material indicated that cervical mucins extended in vitro by polySiaT can contain polymers with more than 50 sialic acid residues (Fig. 7) .
Moreover, the chromatograms suggest that mucins collected during follicular phase can be modified with higher amount of long (DP > 30) chains. However, the structural requirement for polySia to counteract the cellular destruction mediated by extracellular histones was satisfied in both circumstances. Fig. 3 . Sialic acid polymers counteract in a chain length-dependent manner the histone-mediated cytotoxicity. Histone-treated A549 cells were incubated in the presence of sialic acid polymers with different chain length (green columns). Zero percent cytotoxicity was set for untreated cells. All values AE SD are means of three independent experiments. ns, not significant; ***, P < 0.001; ****, P < 0.0001. Thus, the in vitro generated polySia chains have the structural requirements to inactivate the cytotoxicity of histones, as only chains with a DP of~30 seems to be efficient for this task.
Cervical mucins counteract the cytotoxicity of extracellular histones after polysialylation by NmB polySiaT Finally, the biological activity against extracellular histone of the cervical mucins that were elongated in vitro was determined. To this end, the cytotoxicity inhibition assays were performed. Untreated and histone-treated cells were separately cultured in the presence of native or in vitro polysialylated cervical mucins. As expected, the induced cytotoxicity using extracellular histones could be efficiently decreased with in vitro polysialylated cervical mucins, whereas native mucins showed almost no effect (Fig. 8) .
Thus, our results highlighted the biological activity of in vitro polysialylated cervical mucins against histone-mediated cytotoxicity (Fig. 9) . Accordingly, polysialylated mucins might be an option to coat implants or to combat diseases with strongly exaggerated NET formation like sepsis, systemic lupus erythematosus, and cystic fibrosis. Furthermore, polysialylated mucins could be useful for reproductive biology, as neutrophils form NET after Terminal and internal sialic acid residues were visualized by the C7/C9 method. After subsequent metaperiodate oxidation, reduction, hydrolysis, and DMB-labeling, C7-Neu5Ac-DMB and C9-Neu5Ac-DMB were separated by HPLC. Internal sialic acid residues resulted in the detection of C9-Neu5Ac-DMB, whereas terminal ones are detected as C7-Neu5Ac-DMB. (C) For characterization of the chain length, cervical mucins were subjected to the 'mild' DMB method. DMB-labeled sialic acid polymers were separated by anion exchange chromatography according to the DP. Respective numbers of sialic acid residues are given for all peaks on top of the profiles. insemination [39] . DNAses in the seminal plasma will destroy this meshwork but do not result in the removal of toxic histones. As recently described [11] , polySia chains on N-glycans in ejaculates may counteract the cytotoxicity of released histones. Thus, an additional administration of polysialylated cervical mucins might serve to increase sperm survival after natural or artificial insemination.
Experimental procedures

Materials
PolySia-specific mAb 735 and antiserum H46 was purified as described previously [40, 41] . EndoN of the K1-5 phage was expressed and purified as described previously [42] . For dot and western blotting, horseradish peroxidase-conjugated secondary antibodies were used (Dako, Hamburg, Germany). All reagents used were of analytical grade.
Purification of NmB polySiaT
NmB polySiaT was expressed and purified from cells harboring the plasmid pWV239 by a modification of the method described previously [43] . Briefly, a cell culture expressing a chimera of the a2,8 polysialyltransferase and maltosebinding protein was induced with 1 mM IPTG for 3 h. Cells were harvested by centrifugation, resuspended in 50 mM Tris, 25 mM MgCl 2 , pH 8.0, containing 1 tablet of Roche Protease inhibitor (Roche Applied Science, Mannheim, Fig. 7 . Characterization of the chain length after in vitro elongation of bovine cervical mucin. The chain length of elongated (A) luteal and (B) follicular was characterized by 'mild' DMB application after separation by anion exchange chromatography. The DP is given for selected peaks on top of the profiles.
Germany) and lysed in a French pressure cell. The lysate was clarified, centrifuged at 100 000 g to remove membrane fragments and the soluble fraction purified on amylose resin as described previously [43] . Active fractions were pooled and adjusted to a final buffer composition of 14% glycerol v/v, 1.4% D-sorbitol w/v, 150 mM KCl, in 50 mM Tris, 25 mM MgCl 2 , pH 8.0, and stored at À80°C until use.
Purification of mucins
Chicken intestinal mucins were obtained as described in Struwe et al. [44] . Porcine gastric mucin was purchased from Sigma-Aldrich (Taufkirchen, Germany) purified as chicken and bovine mucins. Bovine cervical mucins were purified in an identical manner as chicken and porcine mucins, from animals sent to an abattoir for meat production. Mucus was collected from the bovine cervix at follicular, around ovulation and luteal stages of the estrus cycle. The stage of the estrus cycle was determined by gross morphological examination of both ovaries, assessment of corpus luteum development, as well as mucus characteristics. Peri-estrus mucus was collected from tracts with copious clear mucus, a well-developed follicle, and regressing corpus luteum. Luteal stage mucus (day 6-18) was collected from Fig. 8 . Analysis of the impact of elongated mucins on histone-mediated cytotoxicity. H5B8 cells were exposed to histones (60 lgÁmL
À1
) to determine the cytotoxicity. In parallel, the cytotoxicity was analyzed in the presence of elongated luteal and follicular cervical mucins (green columns) as well as native cervical mucins (60 lgÁmL
; purple columns). In addition, mucins were added without histones (orange columns). Hundred percent cytotoxicity was set for histone-treated cells (blue column). All values are means of four independent experiments. ns, not significant; **, P < 0.01; ***, P < 0.001. tracts with ovaries displaying a large well-developed corpus luteum.
Follicular stage mucus was obtained from tracts with a regressing corpus luteum, a decent follicle, and little or no dry and viscous mucus secretion.
Elongation of mucins by NmB polySiaT
The purified mucins were incubated with NmB polySiaT as follows: Each reaction mixture contains 25 lL of NmB PST preparation (0.9 lgÁmL À1 ); 2. 
HPLC analysis of sialic acid polymers
For detection of internal a2,8-linked sialic acid residues, the C7/C9 method was used [11, 34, 35] . After oxidation, reduction, and fluorescence labeling resulting DMB-derivatives were analyzed on a Superspher 100 C-18 column (250 9 40 mm, Merck-Hitachi, Darmstadt, Germany) at 4°C using a Ultimate nanoLC system (Dionex, Idstein, Germany) [45, 46] . Recorded MS data were processed and analyzed using DataAnalysis Software (Bruker Daltonics). The DP of polySia chains was analyzed by 'mild' DMB-HPLC analysis [11, 35, 36, 47] . Dried samples were dissolved in 80 lL DMB reaction buffer [9 mM sodium hydrosulfite, 1 M b-mercaptoethanol, 20 mM trifluoroacetic acid (TFA), and 2.7 mM DMB (Dojindo, Kumamoto, Japan)], and incubated at 11°C overnight. The reaction was stopped by adding 20 lL 1 M NaOH. DMB-labeled sugar chains were separated on a DNAPac PAc-100 column (Dionex) by HPLC (Smartline System, Knauer, Berlin, Germany) [11] . MilliQ water (E1) and 4 M ammonium acetate buffer (E2) were used as eluents at a flow rate of 1 mLÁmin À1 . Following gradient was applied:
, and T 125 min = 24% (v/v). E2 DMB-labeled polySia chains were detected by fluorescence at 372 nm for excitation and 456 nm for emission. For cell culture experiments, 600 lg colominic acid (Gerbu, Heidelberg, Germany) was separated and collected according to the DP (DP 8-20; 21-30; 31-40; 41-50; 51-60; 61-70; 71-80; > 80) by anion exchange chromatography. Therefore, colominic acid was used unlabeled and after 'mild' DMB derivatization. Collected fractions were then dried by lyophilization and redissolved in water. One percent of these fractions were used for rechromatography by 'mild' DMB analysis (unlabeled fractions) and reinjected directly (already derivatized fractions), respectively.
For quantification, 1% of the collected fractions was hydrolyzed in 200 lL 0.2 N TFA for 4 h at 80°C. DMBlabeling of the dried hydrolysates was performed in 80 lL DMB reaction buffer and incubated for 2 h at 55°C as described earlier [11, 45, [48] [49] [50] [51] [52] . Reactions were stopped by adding 20 lL of 0.2 M NaOH. DMB-labeled samples were analyzed on a Superspher 100 C-18e-RP column (250 9 40 mm, Merck-Hitachi, Darmstadt, Germany) as described for the C7/C9 analysis, coupled to a fluorescence detector (Ex:372 nm; Em: 456 nm).
Agarose gel electrophoresis, western Blotting, and dot blot A 0.5% agarose gel in 40 mM Tris-acetate, 1 mM EDTA pH 8.0 (1 9 TAE) containing 0.1% sodium dodecyl sulfate (SDS) was prepared and samples for electrophoresis were mixed with 109 sample buffer (10 9 TAE, 1% SDS, 35% glycerol, 0.2% bromophenol blue in H 2 O) according to [53] and loaded onto the gel. The gel was run until the dye was close to the bottom of the gel. The gel was then prewashed for 15 min in 4 9 saline sodium citrate (SSC), made from 20 9 stock of 3 M NaCl and 300 mM trisodium citrate pH 7.0, and then placed onto a VacuGene TM XL blotting apparatus (GE Healthcare, Dornstadt, Germany) bathed in 4 9 SSC and the proteins were transferred to a polyvinylidene fluoride (PVDF) membrane under vacuum (50 mbar applied for 3-4 h) following the manufacturer's instructions. The membrane was then rinsed in dH 2 O for 15 min, blocked with 5% nonfat milk in 0.05% Tween20 in PBS for 2 h (wash buffer), and washed twice more with wash buffer for 5 min each time. Horse 46 antisera made in 4% bovine serum albumin in PBS at 1 : 100 dilution (modified from [54] ) was applied for 1 h at room temperature, and then 4 9 5 min washes were carried out using wash buffer as described earlier followed by a 1-h incubation with secondary antibody goat anti-horse IgG (Sigma; diluted 1 : 10 000 dilution in 4% bovine serum albumin, in PBS).
The membrane was then washed in wash buffer (4 9 5 min) and developed using 6 mL of Millipore ECL reagent.
For dot blots, 1 mgÁmL À1 mucins were diluted 1 : 500 in 50 mM Tris/HCl pH 8. One part of the solution was treated with endoN and the mucins were incubated at 37°C for 3 h. About 10 lL of mucins was dropped on a PVDF membrane and dried on a heating plate. The membrane was blocked with Roti-Block (Carl Roth, Karlsruhe, Germany) overnight. Afterwards the membrane was washed several times with Roti-Block and incubated with mAb 735 (1 lgÁmL À1 ) diluted in Roti-Block for 1 h. The membrane was washed again for three times and incubated for 1 h with 1 : 5000 secondary anti-mouse antibody (Dako), followed by washing three times in Roti-Block and once with 0.1% Tween in PBS. For the development were used X-ray films and ECL reagent (Peqlab, Erlangen, Germany).
Cell culture experiments
A549 and 5B8 cells were cultured in RPMI medium (Gibco, Darmstadt, Germany) containing 10% (v/v) fetal calf serum (FCS; Thermo Fisher Scientific, Bonn, Germany) at 37°C, 5% CO 2 . For following experiments, A549 cells were seeded on a 96-well plate with 30 000 cells per well. After 24 h, cells were incubated overnight in 100 lL RPMI without phenol red (Gibco) in the absence or presence of histones (SigmaAldrich). In parallel, histone-treated as well as untreated cells were incubated with different concentration and DP of sialic acid polymers [7, 9] . The 5B8 cells were seeded on a 96-well plate with 30 000 cells per well and incubated for 1 h and 40 min with histones and/or mucins. The cytotoxicity was determined with the lactate dehydrogenase (LDH) cytotoxicity assay (BioVision, Milpitas, USA).
Statistical analysis
Data were analyzed by one-way ANOVA analysis. For multiple comparisons, Tukey's test was applied. The significance and confidence level was set to 0.05 (95% confidence interval). Significances: P < 0.05 (*), P < 0.01 (**), P < 0.001 (***), and P < 0.0001 (****). All values were calculated using PRISM (version 7.03, GRAPHPAD Software, La Jolla, CA, USA).
